0000912282-23-000380.txt : 20230922
0000912282-23-000380.hdr.sgml : 20230922
20230922085501
ACCESSION NUMBER: 0000912282-23-000380
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230922
DATE AS OF CHANGE: 20230922
EFFECTIVENESS DATE: 20230922
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vesalius Cardiovascular Inc.
CENTRAL INDEX KEY: 0001904804
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-492772
FILM NUMBER: 231270319
BUSINESS ADDRESS:
STREET 1: 210 WEST BROADWAY, UNIT 200
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 3W2
BUSINESS PHONE: (604) 559-6162
MAIL ADDRESS:
STREET 1: 210 WEST BROADWAY, UNIT 200
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 3W2
D
1
primary_doc.xml
X0708
D
LIVE
0001904804
Vesalius Cardiovascular Inc.
210 West Broadway, Unit 200
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V5Y 3W2
(604) 559-6162
CANADA (FEDERAL LEVEL)
None
None
Corporation
true
Peter
Skarsgard
210 West Broadway, Unit 200
Vancouver
A1
BRITISH COLUMBIA, CANADA
V5Y 3W2
Director
Executive Officer
Vincent
Ledoux
210 West Broadway, Unit 200
Vancouver
A1
BRITISH COLUMBIA, CANADA
V5Y 3W2
Director
Executive Officer
Other Technology
Decline to Disclose
- 06b
false
2023-09-18
true
true
true
true
Unit offering, each unit consisting of 1 common share and 1 warrant? each warrant may be exercised for 1 common share at CND$6.00 prior to August 29, 2025
false
0
98836
37821
61015
Total remaining to be sold represents 13,650 warrants issued to US Investors, exercisable at CAD$6.00 until August 29, 2025. Does not include securities offered or sold under Reg S. Canadian dollars converted to USD at exchange rate of 1.3426.
false
2
0
0
0
Vesalius Cardiovascular Inc.
/s/ Vincent Ledoux
Vincent Ledoux
COO
2023-09-21